<SEC-DOCUMENT>0001213900-19-008281.txt : 20190510
<SEC-HEADER>0001213900-19-008281.hdr.sgml : 20190510
<ACCEPTANCE-DATETIME>20190510161332
ACCESSION NUMBER:		0001213900-19-008281
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20190508
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190510
DATE AS OF CHANGE:		20190510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38543
		FILM NUMBER:		19815068

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k050819_optimizerxcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B>Date
of Report (Date of earliest event reported): May 8, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; text-align: center; border-bottom: Black 1.5pt solid">Nevada</TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center; border-bottom: Black 1.5pt solid">000-53605</TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; text-align: center; border-bottom: Black 1.5pt solid">26-1265381</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(State or other jurisdiction of incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; text-align: center; border-bottom: Black 1.5pt solid">400 Water Street, Suite 200, Rochester, MI</TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: center; border-bottom: Black 1.5pt solid">48307</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(Address of principal executive offices)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">Registrant&rsquo;s telephone number, including area code: <U>248.651.6568</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&#9744;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#9744;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#9744;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&#9744;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; vertical-align: bottom"><B>Title of each class</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; vertical-align: bottom"><B>Trading symbol</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; vertical-align: bottom"><B>Name of each exchange on which registered</B></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Common Stock</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">OPRX</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Nasdaq Capital Markets</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 8 &ndash; Other Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 8.01 Other Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 8, 2019, the Company held a conference
call to discuss the Company&rsquo;s 2019 first quarter earnings and other matters of business, a transcript of which is furnished
herewith as Exhibit 99.1 and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in Item 8.01 of this Current
Report on Form 8-K (including Exhibit 99.1) shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities
Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth
by specific reference in such a filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 9 &ndash; Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01 Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify; background-color: rgb(204,238,255)">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">99.1</TD><TD STYLE="text-align: justify"><A HREF="f8k050819ex99-1_optimizerx.htm">Conference call transcript dated May 8, 2019</A></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>OptimizeRx Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Doug Baker</FONT></TD>
    <TD STYLE="width: 60%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Doug Baker<BR>
Chief Financial Officer</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: May 10, 2019</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">2</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k050819ex99-1_optimizerx.htm
<DESCRIPTION>CONFERENCE CALL TRANSCRIPT DATED MAY 8, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_001.jpg" ALT="" STYLE="width: 650px; height: 468px">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>C
O R P O R A T E P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo, </B><I>Chief Executive Officer &amp; Director</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker, </B><I>Chief Financial Officer</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore, </B><I>President</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C
O N F E R E N C E C A L L P A R T I C I P A N T S</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D&rsquo;Silva, </B><I>B. Riley FBR, Inc.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry, </B><I>Roth Capital Partners</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels, </B><I>William Blair &amp; Company</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ronald
Chez, </B><I>Private Investor</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi, </B><I>Lake Street Capital Markets</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>P
R E S E N T A T I O N</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon, and thank you for joining us today to discuss OptimizeRx&rsquo;s First Quarter ended March 31, 2019. With us today is the
Chief Executive Officer of OptimizeRx, William Febbo. He is joined by the Company&rsquo;s President, Miriam Paramore, and Chief Financial
Officer, Doug Baker.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
their remarks, we&rsquo;ll open the call to questions. Then before we conclude today&rsquo;s call, I&rsquo;ll provide some important cautions regarding
the forward-looking statements made by Management during the call. I&rsquo;d like to remind everyone that today&rsquo;s call is being recorded
and will be made available for telephone replay via instructions in today&rsquo;s press release in the Investors section of the Company&rsquo;s
website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
I&rsquo;d like to turn the call over to OptimizeRx CEO, William Febbo. Please go ahead.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you, Teshan, and good afternoon, everyone. Thanks for joining us on the call today.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Q1, we realized our 8th quarter in a row of revenue growth, along with record gross margins and continued profitability. These
great results were achieved despite the noise we had experienced at the start of the year at the federal government and corporate
level and with procurement at pharma waking up a little later, which I talked about on a previous call. These record results were
driven by a number of key factors, including diversified revenue streams, broad provider reach, scalable technology and overall
strong operational performance by the team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I
want to be really clear on this call. OptimizeRx is just starting on its path to building a meaningful business, and there is
still so much more room for growth. For the sports enthusiasts, we&rsquo;re in the early innings of a big market opportunity with more
than $1 billion in total addressable market in just one of our many solutions for pharmaceutical clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-acquisition
of CareSpeak, we also increased our growth opportunities further by now trying to solve for the $528 billion incidental cost of
medication non-adherence. Like affordability, we believe our solutions improve patient engagement and adherence, represent one
of the biggest unmet needs in our industry and society, making it a strong investment thesis. There are immense resources being
poured into quality improvement and value-based care, all for the simple reason that it improves outcomes and reduces cost for
all stakeholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unprecedented
capital is going into health IT, multiple acquisitions happening at the service level and HIT level, and a fair amount of HIT
IPOs planned in the coming months. OptimizeRx is absolutely in the right place at the right time, both operationally and strategically.
We have taken our total available market up by a factor of at least two by adding adherence to our solution set. So, if you believed
in the affordability thesis we have been delivering on over the last three years, now we&rsquo;re going after a much larger market opportunity,
well north of $2 billion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Today
our network reaches over half the nation&rsquo;s healthcare providers in the ambulatory market, making OptimizeRx one of healthcare&rsquo;s
leading point of care network where physicians and patients are interacting daily. Through our digital platform, pharma companies
can regain critical access to doctors and their patients and provide the information and savings they need and precisely when
they need it at the point of care. This helps create better health outcomes and a sensational business for all of us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we all saw strong top line growth in Q1, our penetration into pharma still is relatively early. We&rsquo;re connected to many manufacturers,
but we&rsquo;re really only just beginning to penetrate the market. We see lots of room for growth ahead of us this year and beyond.
And, to manage this anticipated growth, we recently hired a Chief Commercial Officer, which I will talk about more later.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Next,
I&rsquo;d like to turn our call over to our CFO, Doug Baker, who will walk us through the financials for Q1. Then Miriam, our President,
to discuss the latest with our platform development, product road map and channel strategy. Then I&rsquo;ll return to talk more about
our results and outlook for the remainder of the year, and then we&rsquo;ll take some questions. Doug?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Douglas
Baker:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Will, and good afternoon, everyone. Prior to the call, we issued a press release with the results of our first quarter ended March
31, 2019. A copy of that release is available on the Investor Relations section of our website. We filed our complete 10-Q this
afternoon as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the first quarter of 2019, total revenue increased 27% to $5.2 million. This was primarily due to increased sales of messaging
products. We currently don&rsquo;t break out revenue by service, but as we achieve greater scale, we plan to determine the best way
to present our growth by service offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of our strong revenue growth, gross margin improved to a record 69.6% in the first quarter. This was up from 51.2% in
the year-ago quarter. The improvement was due to a favorable shift in product mix. We expect to continue to maintain gross margins
of at least 60% on a quarterly basis in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operating expenses totaled $3.5 million, up from $2.3 million in the same year-ago quarter. This increase was related to additional
expenses related to growth initiatives, as well as our acquisition of CareSpeak Communications in October 2018. We expect our
overall operating expenses to continue at the 2019 level, or maybe only slightly above, as we further implement our business plan
and expand our operations to grow the business in a very dynamic and active marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We&rsquo;ve
established a strong team as a base to support our growth, so we don&rsquo;t expect our human resource costs to increase in step with
revenues. We have made additional growth hires in April 2019, including a VP of sales to focus on the hospital market, and as
Will mentioned, the chief commercial officer to focus on enterprise arrangements and product expansion across our customer base.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the first quarter, we saw improvement in our bottom line versus last year. On a GAAP basis, net income was $7,000, or breakeven
per share, as compared to a net loss of $189,000, or a loss of $0.02 per share in the first quarter of 2018. Overall, the income
resulted from increased revenues and gross margin, which offset the increase in operating expenses. We expect to remain GAAP profitable
on a quarterly basis, although one-time expenses related to investments in growth initiatives could result in a loss and any given
quarter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Starting
in the fourth quarter of 2018, we began reporting two non-GAAP financial measures. Non-GAAP financial measures include a net income
or loss and a non-GAAP earnings per share. We believe the use of these measures can be helpful in assessing the Company&rsquo;s financial
performance. We define non-GAAP net income or loss as the net income or loss with an adjustment to add back depreciation, amortization
and stock-based compensation expense. To arrive at non-GAAP EPS, we take that non-GAAP net income or loss and divide by the number
of weighted average shares outstanding on both the basic and diluted basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2019, our non-GAAP net income was up 130% to $833,000, or $0.06 per diluted share, compared to $362,000,
or $0.04 per share, in the same year-ago period. For additional information about our use of these non-GAAP measures and their
reconciliation to GAAP, please see today&rsquo;s press release.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Turning
to our balance sheet, cash and cash equivalents totaled $10.1 million at March 31, 2019. This compares with $8.9 million at December
31, 2018. The increase was primarily due to cash generated from operations and proceeds from the exercise of stock options. We
have continued to operate debt free, and in fact, generated operating cash flow of $890,000 in Q1, and we expect to continue to
generate positive cash flow from operations on a quarterly basis for the balance of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the capital we raised earlier last year and positive cash flow for the foreseeable future, we don&rsquo;t anticipate needing to raise
any additional capital solely for operating purposes. We&rsquo;re focused on growing our revenue channel and partner networks organically.
However, as a Company operating in this market active with mergers and acquisitions, attractive opportunities may arise, like
for acquisitions or strategic relationships. We plan to assess these as they arise with a view to maximizing shareholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
wraps up our financial results, so now I&rsquo;d like to turn the call over to Miriam.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Doug. Hi, everyone. Underpinning these great results is our unwavering commitment to better affordability and adherence solutions.
We achieve this by improving the lines of communication between pharma, providers and patients. Bringing these stakeholders together,
we create a seamless communication platform that improves the healthcare industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April, we announced our latest platform integration with the health care&rsquo;s industry-leading acute hospital EHR systems that include
Epic and Cerner. By linking our platform to the industry&rsquo;s leading EHRs, hospitals and health systems across the country, we gain
access to critical information from patient savings opportunities to mediation adherence information that empowers the patient
with lower cost plus high-touch support programs. Hospitals and health systems benefit from reduced readmissions, increased patient
satisfaction and improved quality of care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
latest integration was borne out of our continued investment in hospitals and health systems, including our recent appointment
of Denys Ashby to the new position of Vice President of Hospital and Health Systems. I&rsquo;ll come back to Denys in just a moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OptimizeRx&rsquo;s
technical connection to Epic and Cerner enables healthcare providers to provide patient savings opportunities for nearly all medications.
Research points to improved medication adherence when patients can identify ways of lowering their copayment, and adherence helps
to prevent readmission, which is important to hospital quality scores and thus their top line revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
back to Denys. We expect Denys to add significant value to our hospital and health system strategy, leading the expansion of our
ecosystem. He&rsquo;s a proven leader with more than 25 years of experience in sales across the healthcare, pharma, pharmacy automation
workflow and clinical solutions markets. Denys most recently served as National Director of Business Development at CaptureRx
and has held leadership positions within McKesson, Cerner and ScriptPro.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
to focus on adherence a little more deeply. As Will mentioned earlier, according to a recent study, the lack of medication adherence
costs the U.S. health system as much as $528 billion in terms of illness and death that results from poorly followed medication
therapy. Patients are at risk of contributing to this public health challenge when they avoid filling or refiling prescriptions.
There are strategies that could help manage this risk in order to lower care costs and improve people&rsquo;s health. We need to address
this through an ecosystem-wide holistic lens.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
acquisition of CareSpeak last fall, and our recent expansion into health and hospital systems, provide us with the technology
capabilities to deliver savings and adherence messages across the entire care continuum. Our platform now reaches providers who
prescribe the medications, patients who take the medications and hospitals who deliver care when needed. We expect good growth
and margin contribution from the CareSpeak patient engagement product line, given the industry need for digital solutions to engage
healthcare consumers across their healthcare journey.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
a bit more about our new hospital partner, IllumiCare. In Q1, we partnered with IllumiCare, a pioneer in point of care healthcare
information technology that focuses on saving hospitals money. Their Smart Ribbon platform will be featuring a new app from OptimizeRx.
This app will present drug savings opportunities, such as copay offers and vouchers, that providers and clinical care teams can
distribute to the patient directly at the point of care. Hospitals and health systems who use IllumiCare solutions will be launching
soon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
other channel news, we are continuing to grow our EHR channels across two trajectories. We continue to add new channel partners,
and as they scale, we add new providers to our network. At the same time, we are finding ways to expand the number of ways we
communicate to providers within each EHR channel. For example, we currently connect pharma manufacturers to the provider in real
time at the point of prescribing. We also provide other clinical content at the same point in the EHR workflow. But in addition,
we are finding other valuable ways to communicate in other points in the workflow such as login screen. This expanded digital
footprint within an EHR channel is a revenue multiplier.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
I&rsquo;ll turn for a moment to our new innovation, our multi-specialty physician panel called OptimizeMDs. We announced this is in
Q1, and we created this panel with a mission for having a provider voice in the conversation. This panel provides that critical
voice of the physician and helps us along our mission to streamline communications between pharma providers and patients. OptimizeMDs
provides us a way to gather timely information about the challenges physicians face with prescribing decisions, medication affordability
and patient support, particularly while using the EHR in their day-to-day practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Later
in the quarter, we announced the results from our first OptimizeMDs survey about drug cost in which we polled 600 providers. The
survey showed that providers want to actively engage their patients in a discussion about cost as it affects adherence and improves
care. Shared decision making between patients and prescribers is more important than ever, and the cost conversations and discussions
around access will be central to the patient-prescriber relationship. We&rsquo;re working hard to fill this communication gap so that
providers can successfully address cost challenges and improve consumer loyalty and trust. Given how early we are in our Company&rsquo;s
evolution, we anticipate continued investment in our commercial reach, products, channel partners and best-in-class team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
that, I&rsquo;d like to turn the call back over the Will.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Miriam and Doug. I&rsquo;m pleased to say our clients and partners came back strong after a late start to the year, supporting our confidence
in what will be a great 2019 and beyond. With continued limited competition, we are doubling down in this space, which says how
much we see here in terms of opportunity. It&rsquo;s a clear indication that our recent announcement to build out the commercial and
channel team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April, we appointed Stephen Silvestro in a new position of Chief Commercial Officer to manage our growth. Let me be clear; Steve
was not hired to fix anything. We have a great team and they&rsquo;re executing. He was hired to manage growth, which as anyone who
has run a fast-growing business knows is critical to keep the momentum. We&rsquo;ve reached scale with our clients based on where we
can now negotiate enterprise pricing, and Steve will be laser focused in this area, which is one of his expertise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steve
brings to OptimizeRx important experience, depth of knowledge and a shared determination to provide affordability and adherence
solutions that link the healthcare and life science industries. During his tenure at Decision Resources Group, he was an instrumental
leader in the growth of the Company from $30 million in revenue to $180 million in revenue to an exit. His customer-first philosophy,
and just a great guy, is clearly aligned with our values at OptimizeRx. We are very happy to have him on the team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are confident in the market appetite for our solutions as well. We believe Steve will drive incredible growth with our core clients
and take the Company to the next level in terms of reach, revenue and earnings. No one does that alone, but we think his leadership
will really accelerate the existing team.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recently partnered with EVERSANA to get more connectivity with specialty drugs in the electronic health record workflow. Specialty
drugs typically have lower volume through the adherence platform. As you may have all read, specialty drugs are the dominant new
brands coming to the market in the next few years. So, having this type of partnership allows us to leverage our network, get
more client penetration and help more physicians and patients with expensive medications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
partnership will improve patient access and adherence challenges as biologic and biosimilar developments bring more expensive
specialty drugs to market. Our real-time EHR network will seamlessly integrate into EVERSANA&rsquo;s patient support and specialty distribution
models to expedite the process from diagnosis and enrollment to affordability solutions and ongoing patient support.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regarding
M&amp;A activity in the space, we continue to focus on adding additional capabilities and patient engagement affordability and
patient-physician access. We believe this is a critical piece to our overall growth story to be more and more relevant to our
client base. Over the next few months, we anticipate two or three announcements related to general channel or HCP and patient
reach access and continue to build out our commercial team. We also continue to enjoy tremendous market opportunity with a lot
of room to grow, and we are perfectly positioned between all the stakeholders: pharma, physicians, patients, and our platform
enables multiple revenue streams, which helps all of us with the focus on affordability and adherence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">So,
for the remainder of the year, we&rsquo;ll remain focused on generating revenue growth from our core solutions, expanding our network
in the hospital market, seeking solid M&amp;A opportunities and driving additional revenue through our partnerships. All these
efforts give us confidence we can expect continued adoption of our health platform across our entire client base.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the growth in both our pharmaceutical products and our distribution network, we expect that our financial, brand, clinical messaging
to continue to grow throughout the year, along with our increase in patient engagement activities. All this is expected to drive
another strong year of growth with strong margins and profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
look forward to seeing some of you at the upcoming investor conferences over the next several weeks, which include the Oppenheimer
Emerging Growth Conference, the B. Riley Conference and the Ladenburg Thalmann Technology Expo in New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
with that, I&rsquo;d like to open it up to your questions. Thank you.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you, sir. If you would like to ask a question, please signal by pressing star, one on your telephone keypad. If you are using
a speaker phone please make sure your mute function is turned off to allow your signal to reach our equipment. Again press star,
one to ask a question. We will pause for just a moment to allow everyone an opportunity to signal for question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&rsquo;ll
go first to Andrew D&rsquo;Silva with B. Riley FBR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D&rsquo;Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon and thanks for taking my questions. Just a couple quick ones for me. First one, just couple bookkeeping ones. If you
could just maybe bridge the gap and let me know what kind of impact you, maybe back of the envelope, estimate the government shutdown
had on your top line during the quarter. And then as it relates to gross margins, just curious, you mentioned product mix being
the reason for the substantial increase. Can you give a little bit more color on that? Is it related to not having any more related
party fees or is there some other mechanism at work?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hey
Andy. Thanks. Don&rsquo;t have a hard number for you. So we have pretty aggressive internal goals and&mdash;but I&rsquo;m not going to give
you a hard number on what was missed. But it was a good maybe 10% more, more or less, but we see that coming back through the
year, as we&rsquo;ve talked about.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And,
relative to mix, yes. One of the challenges when I came into this business was we had one product, a very concentrated customer
base, and now we have multiple solutions, a broader customer base, and so the difference would be we had more revenue in a product
or service. We didn&rsquo;t share as much to third parties, so that&rsquo;s exactly right. And that, I think that&rsquo;s the key going forward
is we&rsquo;re not going to be so handcuffed to the rev share as a big piece of our cost. The team&rsquo;s done a great job with our existing
partners and contracts such that we&rsquo;re heading in the right direction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Andrew
D&rsquo;Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay,
great. Then just moving over to the technical integration with Epic and Cerner. Can you give a little bit of insight into what
exactly needs to take place from going from a technical integration to being actually deployed across a health system? What kind
of interaction you would need to have with Epic and Cerner for that to be implemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Miriam
Paramore:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
I can take that. So, think about our hospital strategy now as having multiple prongs. We mentioned that we hired Denys Ashby to
lead that up, and in that regard, we are going to market and actually talking directly to the executives in various hospital systems
and health systems about the business benefit and the patient benefit that this can bring, and then we&rsquo;re getting to the right
decision makers within the hospital system through those executive lead-ins, which that&rsquo;s not something we did before. So, we&rsquo;re
going directly to them. Then secondly, we&rsquo;re going through existing channel partners, Medicom and IllumiCare, and we&rsquo;re continuing
to look for new channel partners. So, two different prongs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regardless
of which prong we use, there could be a set of technical work to turn it on in order to get the flow of the messages moving, if
you will. In our case, what we mean by technical integration is that we are now technically integrated into those workflow components
like the medication history component or the discharge workflow. There&rsquo;s an admit discharge transfer functionality in all health
hospital system IT that the ADT&mdash;it&rsquo;s what it&rsquo;s abbreviated as&mdash;that&rsquo;s used whenever someone checks in, registers and
is admitted, or whether they&rsquo;re discharged or transferred to another facility. That&rsquo;s a specific piece of the workflow, and there&rsquo;s
a data exchange there. So, what has to happen to turn a hospital on is the executive team says, yes, we want to do this, and the
hospital IT team has to accept that handshake. It is a process of connecting those APIs together, the ones that we are connected
into and really turning them on. And that could happen either directly or through a channel partner. Does that answer it?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andrew
D&rsquo;Silva:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
absolutely. That was really, really colorful insight. Thank you. I guess my last question is just going to be related to specialty
products, specialty branded drugs. Obviously you announced a partnership with EVERSANA. But I&rsquo;m curious, could you run me through
what a specialty financial messaging partnership looks like right now, and then how would it change going forward with the partnership?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andy,
we don&rsquo;t want to get into too much detail, because while we don&rsquo;t have a lot of competition, they all listen to this. But in essence,
instead of just having a flat fee for a brand, which is specialty which would be a lower volume, we&rsquo;ll be able to work with other
messages that help the patient and the doctor and charge for it differently and at a higher price point. So, we don&rsquo;t want to
get into too much detail there, but it&rsquo;s&mdash;let&rsquo;s just say it gives us a very comprehensive solution to the wave of specialty
products coming, and we believe it&rsquo;ll give us a nice bump in stickiness, value and price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
we&rsquo;ll take our next question from Richard Baldry with Roth Capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Richard
Baldry:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks.
You mentioned that product mix benefitted gross margins, which were obviously pretty strong and set a pretty strong new high.
Can you talk about what the seasonal factors would be as the rest of the year sort of plays out, and what your thoughts are on
blended gross margins in sort of in maybe an intermediate-term target or a long-term target? Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hey
Rich. Thank you. As Doug said, I think 60% is a good percentage to use for modeling going forward. I think we really have nice
diversification here, and we&rsquo;re trying to leverage all of them. I think with Steve sort of managing those from the commercial
perspective, we&rsquo;ll see&mdash;we should just look to 60%. The seasonality, it was a little higher in Q1 than we thought, which
we won&rsquo;t complain about, but generally it gets a little bit better towards the end of the year. As we said last year, we had that
because we sort of had a fixed cost against some inventory with a partner. We don&rsquo;t have that this year. So you shouldn&rsquo;t expect
big material swings. I think it&rsquo;ll normalize to 60%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
when we think longer term, though, your core financial messaging has got some pretty good scale, but your newer adherence or non-financial
messaging is much smaller. So should those see natural lift or meaningful lift as you get greater scale in them? And does the
drive sort of a longer term target that would be above that 60% level?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absolutely.
That was one or one of three pieces why we really liked bringing CareSpeak into the business. We believe long term it will absolutely
improve our gross margin since it&rsquo;s nearly 100% contribution. So yes, that is why we brought it in. What we&rsquo;re working really
hard at on that side is getting it to be inside a model of scale versus project. And so it doesn&rsquo;t happen overnight, but we think
we see where it could go. And, that&rsquo;s also I think why this EVERSANA partnership will be helpful to be able to work on that more
directly with specific clients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Richard
Baldry:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Great.
Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Rich.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&rsquo;ll
take our next question from Ryan Daniels with William Blair.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
Good evening, guys. Thanks for taking the question. Well, maybe one for you upfront&mdash;sorry for that. Maybe one for you upfront.
You talked about procurement being a little bit off with some of your pharma representatives in the first quarter, given some
noise in the marketplace and questions on ROI from some other vendors. I&rsquo;m curious if you&rsquo;ve seen that normalize into Q2. And
then concomitantly, what the pipeline for new pharma sales is looking like for the second half of the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes,
sure. We did see that normalize sort of towards the end of Q1 into Q2. Pipeline looks very strong and feel good about what&rsquo;s going
on. I think the&mdash;we talked about it a little bit. One client in particular wanted some technology enhancement as part of
their EHR strategy. We&rsquo;ve been able to do that. We&rsquo;re testing it. We think that&rsquo;ll also bring some business back. So, very confident
about the pipeline. Feel good about not just our core offering, but I feel good about CareSpeak and I also feel good about partnership
revenue. So, feeling pretty strong about the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Great.
And as we look at the CareSpeak kind of integration activities, I know you had called that out as a potential cost headwind during
the year. Clearly it didn&rsquo;t impact performance this quarter. I&rsquo;m curious, is the integration largely complete? Is there a lot
of technology buildout that you foresee in that product offering, or is it kind of where you want it? Just any more color you
can offer on that as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I&rsquo;d
say the integration is complete. We&rsquo;ve got the sales team trained, got the teams working together. Their technology was ready
to go when we bought them. So, there&rsquo;s certainly a product road map for enhancement, more integration into the EHR network and
other partners. And, I think it&rsquo;s&mdash;that&rsquo;s an area where we will continue to invest. It&rsquo;s, as you know, just a gigantic problem,
and if you can move the needle at all, you become very valuable to the pharma client base. So, that&rsquo;s where we think this combined
value prop of adherence with affordability is just so strong. We&rsquo;ve seen cases of adherence programs that include a copay connected
to it and those that don&rsquo;t, and hands down those that have both are much more effective for the patient, which helps the doctor,
which helps the overall system. So, I would say we&rsquo;re very happy where it is. Still have work to go. I think the strategic thing
we&rsquo;re working really hard at is just trying to get it to be more scalable and get away from project-based pricing. That&rsquo;s the
part that we&rsquo;re working really hard on. But the team is absolutely executing and doing a great job.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Super helpful. Then final question goes back to gross margins. I think everyone has asked about that because it was such a pleasant
surprise during the period, and you took up your annual guidance by about 500 bps from the 55% level. But, I believe you mentioned
that you&rsquo;re no longer tied to a revenue share for some of the financial messaging. So I&rsquo;m curious if you&rsquo;ve actually moved the
way that your cost of services are paid to some of your EHR vendors, or did I misinterpret that? Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
No, we are still a revenue share with all our partners. This was just a product mix benefit inside of Q1. But yes, we still&mdash;what
I said on the revenue share is we&rsquo;ve been doing a better job just getting better rates for OptimizeRx because we&rsquo;re starting to
get some scale and size and using that to get our costs down.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ryan
Daniels:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
Okay, that explains it. Great. Thank you so much. Congrats to the strong start to the year. Thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Ryan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&rsquo;ll
take our next question from Eric Martinuzzi with Lake Street.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have a question about the revenue outlook. I know you&rsquo;re not giving guidance for 2019, but given the shortfall that we had in
the month of January, and we were still able to put up a 27% growth on the quarter. Right now, the Street estimates are anticipating
34% growth for the year, which would imply some acceleration out of you guys in the out quarters. I&rsquo;m just wondering if that&rsquo;s
something that you&rsquo;re comfortable with or is it too soon to say? Again, not insulting 27%, but just to know is there the potential
for acceleration year on year in the out quarters?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hi,
Eric. Yes, absolutely comfortable, and yes, there&rsquo;s room for acceleration starting in Q2 and beyond. Remember, the market is big
and we have just begun and there&rsquo;s just so much going on. I think we&rsquo;ve also gotten a ton of credibility. You look at partnerships
like our EVERSANA. There&rsquo;s going to be things that we didn&rsquo;t put in our internal projections that hit us over the next three to
six months, which do affect revenue in the short term. So yes, we feel good about our growth this year. Still not ready to do
guidance. Maybe we&rsquo;ll grow up enough by the end of the year and think about it next year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
And then organizationally here, with the arrival of Stephen and the Chief Commercialization Officer position, who exactly was
kind of doing those duties, or was it shared between a couple of different executives? Then what does it mean for sales hiring?
Do we have targets? Where are we now with sales reps, and where do we hope to be as we enter the RFP season come into Q3, beginning
of Q4?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
So, to your first question, it was Terry Hamilton, who really helped start the Company, was handling most of it. I would help,
Miriam would help. I think what this allows us to do is have Terry really focusing on the ground with the team. We have multiple
different revenue sets and solutions, and our job is to keep closing a lot of business, but at the same time, going up the food
chain within our client base looking to get enterprise pricing. That is a skill set and function in and of itself. An example
of that is you have a client doing maybe $1 million or $2 million a year with one of the HCP access disease states, and you want
to go up to the person who oversees three of those disease states and say, look, for $10 million a year, we&rsquo;ll do this. And here&rsquo;s
your discount and here&rsquo;s what we do and here&rsquo;s how we measure it. And that is&mdash;it&rsquo;s very hard to ask a sales person who&rsquo;s
closing the day-to-day business to go up and find the executive. That&rsquo;s not an easy thing to do. So, what Steve will do is support
the sales team in getting to those conversations, and so that&rsquo;s not something we were doing at all, really. We had a couple select
clients we were trying. This will allow us to do a lot more of that. I think&mdash;so I think that answers the first part of your
question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
second part is as we said, we hope to get at least&mdash;we wanted three hires this year, so it&rsquo;s probably additional two sales
people hired before September 1, and obviously having come from a couple large organizations with lots of really good commercial
people, we expect that to happen between now and August.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Okay.
And then last question is on the profitability. You talked about the expecting to be GAAP positive on a quarterly basis with the
exception of some potential investments. Is that to mean if we wound up doing M&amp;A, there might be restructuring charges that
would take us to a negative GAAP number? Is that what I&rsquo;m&mdash;the implication by that comment?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
know, I think Doug has said that one before. I think it&rsquo;s a good catchall. There&rsquo;s lots of things that could happen. You have
deals could happen. There could be some technology we&rsquo;d want to buy and it would just have to flow through the P&amp;L for some
reason. So, I think it&rsquo;s more of a safeguard than anything, but yes, those are a couple reasons why it could dip down.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eric
Martinuzzi:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Got
you. Okay. Good luck with the rest of the year and thanks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Eric.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We&rsquo;ll
take our next question from Ronald Chez, a private investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ronald
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Good
afternoon, Ron.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ronald
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
was wanting to try and wrap this into one question about what appeared to be significant opportunities. Is this, in terms of focus,
heaven help us from too many opportunities, or are you able to focus and deliver the way you want to in each of these opportunities&mdash;with
each of these opportunities?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
No, good question. So I think we actually were incredibly focused and we have guardrails so that we don&rsquo;t go crazy. With affordability,
we understand it incredibly well. We&rsquo;ve been growing it like crazy, and we expect to continue to do that. Adherence is new to
us, but not to CareSpeak. We now have a sales team that&rsquo;s been trained on it, and we expect to grow that quite a bit. The two
together are incredibly powerful such that now we can look at other partnership revenue. But, this partnership revenue is just
enabling what we do. It&rsquo;s not additional things. It&rsquo;s using a network which we own, which people have to sort of pay to use, and
it allows us to help patients and physicians, which is wonderful. So, to your question, no, I don&rsquo;t think it&rsquo;s too many things
so it&rsquo;s you&rsquo;re going an inch deep and a mile wide. I think we&rsquo;ve got two sectors to focus on. We want to get the doctors and patients,
so two communities, and we&rsquo;ve got one client set, which is pharma. And as you know, they&rsquo;re big and they have a big problem with
communicating with their client base, so we hope to help them with that.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Ronald
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
know you want to, and you&rsquo;ve said this don&rsquo;t want to provide guidance now, and I agree with that significantly. You spoke to visibility
as well. Doesn&rsquo;t the involvement with the hospital systems significantly expand the total addressable market?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
does. It absolutely does. Keep in mind, most of the prescription volume is on the ambulatory side, but every hospital system we
connect to is new to us and new to our client. So, we expect that to help our reach this year. And as we show pharma that and
we do pilots in certain hospital systems, we expect they&rsquo;ll be positively received. And yes, that does help us. I think, as I
said in the beginning, I think our TAM just doubled just on affordability and adherence being combined. And, as we get our arms
around the actual reach to HCPs and patients as these integrations happen, my guess is it&rsquo;s going to get even bigger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ronald
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
think&mdash;last thing, I think you have significant opportunity to build the business. A lot of the steps that you&rsquo;re taking
now will allow for that and better diversification as you spoke to. In the area of any acquisitions, you will be sure to be cautious
complementary. Acquisitions don&rsquo;t dilute too much.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absolutely,
yes. No, the good thing about everyone on the team being a shareholder is everyone wants the share value to go up. So, we will
not be loose in any way with the finance or equity, and feel like we&rsquo;re in a good spot to find some opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ronald
Chez:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appreciate
the time, Will.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks,
Ron. Take care.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
right. At this time, that concludes our question-and-answer session. I&rsquo;d now like to turn the call back over the Mr. Febbo. Please
go ahead, sir.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>William
Febbo:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thanks
to everyone for joining the call. If you can take one thing away from this call, just hear our belief in our potential to deliver
strong revenue growth, margin improvement and a broader industry profile this year, and it will be impressive. I believe we have
a culture dedicated to doing something that makes a difference, that has a positive impact for physicians and patients. When you
can do that and grow and be profitable and be very early in that process, we believe that translates to an excellent investment
opportunity. So, I look forward to seeing everyone over the next month or so in various cities, and from the whole team, thank
you for the attention. We appreciate it. Bye bye.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance of the conference call. This transcript is being made available for information purposes only.</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><IMG SRC="eximg_002.jpg" ALT=""><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Operator:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and gentlemen, now before we conclude today&rsquo;s call, I would like to provide the Company&rsquo;s Safe Harbor statement that includes
important cautions regarding forward-looking statements made during today&rsquo;s call.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
made by Management during today&rsquo;s call may contain forward-looking statements within the definition of Section 27A in the Securities
Act of 1933 as amended, and Section 21E at the Securities Act of 1934 as amended. These forward-looking statements should not
be used to make an investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
words anticipate, estimate, expect, possible and seeking and similar expressions identify forward-looking statements, and they
speak only to the date that statements was made. Such forward-looking statements in this presentation include statements regarding
estimation of total addressable market size, revenue growth, gross margin, operating expenses, profitability, cash flow, technology,
investments, growth opportunities, acquisitions, upcoming announcements and the need for raising additional capital. They also
include the Management&rsquo;s expectations for the rest of the year and adoption of the Company&rsquo;s digital health platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information,
future events or otherwise. Forward-looking statements are inherently subject to risk and uncertainties, some of which cannot
be predicted or quantified. Future events and actual results could differ materially from these set forth in are contemplated
by underlying forward-looking statements. Risk and uncertainties to which forward-looking statements are subject to could affect
business and financial results are included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31,
2018. This form is available on the Company&rsquo;s website and on the SEC website at sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
we end today&rsquo;s conference, I would like to remind everyone that this call will be available for replay starting later this evening
and running through May 29. Please refer to today&rsquo;s press release for dial-in replay instructions, available via the Company&rsquo;s
website at www.optimizerx.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you for joining us today. This concludes today&rsquo;s conference call. You may now disconnect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ViaVid has made considerable efforts to
provide an accurate transcription. There may be material errors, omissions, or inaccuracies in the reporting of the substance
of the conference call. This transcript is being made available for information purposes only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1-888-562-0262 1-604-929-1352 www.viavid.com</P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>eximg_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 eximg_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" +/ ^8# 2(  A$! Q$!_\0
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MH_X;H_ZI=_Y>_P#^"-?%'_"#>-O^A/\ %/\ X3^K?_(E'_"#>-O^A/\ %/\
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M[9_X;H_ZI=_Y>_\ ^"-'_#='_5+O_+W_ /P1KXF_X0GQG_T*/B?_ ,$&J_\
MR)1_PA7C(]/"7B<_]P'5?_D2CV=3_GW4_P#!=3_Y /;T/^?]#_P?1_\ EQ]L
M_P##='_5+O\ R]__ ,$:/^&Z/^J7?^7O_P#@C7Q-_P (3XS_ .A1\3_^"#5?
M_D2C_A"?&?\ T*/B?_P0:K_\B4>SJ?\ /NI_X+J?_("^L8?_ *"*'_@^A_\
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M?^#Z'_RX^V_^&Z/^J7?^7O\ _@C1_P -T?\ 5+O_ "]__P $:^)/^$,\8?\
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M_P#_ !BG[&M_SYK?^":O_P J#ZY@_P#H+PG_ (5X7_YI/N7_ (;H_P"J7?\
ME[__ ((T?\-T?]4N_P#+W_\ P1KX8_X1SQ#_ - +6?\ P5WW_P 8H_X1SQ#_
M - +6?\ P5WW_P 8H]A7_P"?%?\ \$UO_E(OKF#_ .@S"?\ A7A?_FD^Y_\
MANC_ *I=_P"7O_\ @C1_PW1_U2[_ ,O?_P#!&OA?_A'?$'_0"UC_ ,%E[_\
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M?_-1]V?\-T?]4N_\O?\ _!&C_ANC_JEW_E[_ /X(U\)_V'K7_0'U3_P7W?\
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M?>'_  W1_P!4N_\ +W__  1H_P"&Z/\ JEW_ )>__P""-?!W]E:I_P! V_\
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M_P#Q%!LKP=;2Z'UMY?\ XBCZKBO^@7$_^$V(_P#F</[1R[_H89?_ .%^!_\
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M#L<]$8_\!/\ A1L?^XW_ 'R?\*/JF+_Z!,7_ .$N)_\ F8/[4RO_ *&F6?\
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M[ID()'2DZTXJ0,\?A_\ JIM69N#2NVM/4B:,L3G&,YZFH@I4L/?^6:M4V12
MIXY_^M000T444&4HVNUM^(444X*2,C%5'1[-Z/8@;12D$'!I*V3O_6P$;(22
M>/\ (^E1G@D>E6*@;J?J?YTN57OKO??2_H E1,I&3QR?\:EHH:O;NMOZZ@5Z
M*FV+Z?J?\:AIJ_6WR=_T0"'D$>H-0D$'!J>CK0!7HJ4JN#QV]345 !1110!]
MC?L1?\E6\0?]D]U;_P!23PG11^Q%_P E6\0?]D]U;_U)/"=%?D7&?_(]J?\
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M*-A]1^O^%2T58%>HRGH?S_\ K"K.P>_^?PJ*IC?K^=_T5@(""#@TE2NI//'
M_P :BJ@&L1]WN1QZ<\4S8?4?K_A4M% $)0@9X_S^%-J<C(Q4;+C)'3]?\YH
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MQS]?\::DGMT(G%NUNEQE%%%,CDEY?>%,9<Y(SG\*&+#/ QZ_Y/K3=Y]!^O\
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MR?7)'_UJME0V,YXIA3IC)]<D?_6JS%P=W9*WJ5"".M,9<\\YQQ5@J#U_2HV
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MMNMK@?8?[$O_ "57Q!_V3[5?_4C\*44?L2_\E5\0?]D^U7_U(_"E%?D?&?\
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M^WTQS]:A9?4=<XZ?I5D@CJ*0@'J ?K0250H';/UP:1D!Z<''&,8JP4!Z=<<
M8 J,@CK0!7((X(J-D')'7TXQ5H@'K^?>H6&"1_GI0!7((.#32H/^(ZU*^>>!
MCCGOV]_PJ.MULO1?D<4XOFF]+<SZ^9"5(^F>.E0%6)/'<]Q_C5W /49J-D].
MN>G&*9']>I0V#U/Z?X4UE"XQGG/7\*NE,=5'/TJ%U QWZ]<&@EQ\[^NWX)/\
M2K2-T/T/\JE< 8P .O\ 2HZ#)K2ZO9_\-J5Z:4!/<?3'^%6"@/M],#^E-9
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M^Q,I'Q5\0$C_ )I]JOI_T,?A2BI/V*?^2J:__P!D_P!5_P#4C\*45^1<9?\
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M^2I:_P#]B!JO_J1>%:*_(>,E;/*B_P"H3!?^FZO:Q_4OA+_R1M#_ +&F;?\
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MM] IA0$\<?A_]>GT4TVMG8?-I9J_K_FM2(I@$YZ>W_UZ94Y&01ZTSR_?]/\
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M<GW[Y/K5;:?0_D:TOY=%;5_?\S.4;:/R_J^Y"4(QC)_"F$ ]0#]:L5'Y?O\
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M5=D(Z>O3'(K1\OW_ $_^O5=T()[\GH*:E:_?\_+R]=WU,BI@^A_(U'Y3>_\
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M;?B0,N.#W%1E5P>.WJ:F?J/I_4TRBRM9Z^NI#6SMTT95?E2/\]:K[%]/U/\
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M?\*C;;U!))/^>U 6?9_<R%D[CG).:C9.F<CKCD>WUJQ3'!.,#U_I51^)?/\
M(4HMIJS7G8K%.F,GUR1_]:H2H)R<U<V-Z?J/\:A<$G/8#G]:UNNZ^]&#BUT?
MRU*K  X'I_C3:L'D$>M,V#U/Z?X4<R[K[R7"_P!F6O5(BIC+G)&<_A4Y08XS
MG\*800<&CFCW1FX3Z1E;T*Y!!P:B9.XR23[5;(!&#414CZ9XZ5=.4;O5;?KZ
M$N,H[IKU16*D=1_*FE0V,YXJP0",&H6!!]N<5KS+NOO(E%/R?<K5&4 !// /
MI_A5@ITQD^N2/_K5&>01ZU+<4DM';MT_'Y]=3)JW>WFK%>HW!)SC@#_&IRAS
MQR/J/_K4FQO3]1_C0I*^]T];OIY,SE%+5+RM;OUWZ%6D(R,599&VGC]1ZU"5
M(Y(_45O"4;/5;]_(CE5NS[/=^FVY792,^GKQ_GK3" 1@U9J(JV3QW]15\T>Z
M):Z/YE65/E&,DY[X]#]*K,AQR,<^W_UZONC8].?7Z^F:KM"QSCKGN1C_ !J7
M*%]9)/O?4SE%;I?)?\,_T*)!'6DJUL;T_4?XU%Y+^WYTU)7LVO)WW]/3U,R*
MFLN>><XXJ4IM^]P2.,<_GQ3*I.^W]>AG*-VVM^J>S]" @C@CWJ/!WY[?_6Q5
MINA^A_E4%!/*[-V:UVLRNZ!G/7)QZ=@*@>+!).>W<>@J_43J<D]N/\*N,G>S
M>ENIG**[:WU_X/EWV,QE!R.>#_C4)4CZ9XZ5?D0D9XY;W]_:H#$2,$C\_P#Z
MU7S1_F7WF?++L_Z^95I"H;&<\5(Z[<=>^<^U,JEJ9N*W6C[H@((ZBHF08/)Z
M'T]/I5RH"C8/'8]Q33:V9GRMW=FFNG1^GIZLHLF.G3'/2HR,C![U;*-TZY'8
M_P"-,,9"D?S(]1Z5M&]E??\ K<AKI;6S5[;7*A08XSG\*8R''(P#[CZ_TJUL
M/J/U_P *8Z-M/&>GIZ^],S<+IJS3LTNS\_5]BD4.>!Q]14;+G@]C5O8WI^H_
MQJ)DY..N><]/T%!SN$ET=N]K%5E &1GK_C4#)Z?B./TJX>"1Z5&4]/U_I@52
MO&[L_GM_P?O7Z$\LNS*=-90?KV_^O5JF.I.,#U]*U3;O=6M\[F33:;Y6GT\_
M^&*9!'6F%03DYJV01UJ)E).0.WM5)M;72,IQ?+L[W73]>_EU*S+CD=/PJ%ES
MDC.?PJX01UJ)U.2W&./KV%6IMV3[K6_YZ?Y&7+)=&4V7J#_GO4+*1],\&KK#
M((J+8WI^HK1:;/K]WD9RAOI9[[:O\2K4;)W&22?:K3QD<X/)]1[U'L;T_4?X
MUI&7=[:W[^6W0RY7V=^]KE6BIRH;&<\5&RA<8SSGK^%:1M)7;MVZKKN8SC:U
MDU>_3?T[V(F4'GOCCTJ$@]#QD58II(Z$XR*-G_D39[6?I8J.@VMC.<'TJML;
MT_4?XUH$+D8/'<_Y']*8XR"%YZ8_3Z5:O+HF_/M^'4QE'72+5M'IU*)!!P:
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MU_QIE%% )6ZM^O\ PR"BBB@84444 (0",&HBI'TSQTJ:C /49H KT5(X '
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MT@WQY^,?CCXJ?\(^U@-%'B_53J0TW>/#18VNZ-#&6^TS@XX/FOW-6_\ @\$
M'[*7[+A''_&0DXQ_W3?QO7SS_P &?@RG[5.1D;M._EX4KP93G_;48\TN6\?=
MYGR_P6_AO;?78^UA2I?ZI3J>RI^TM/\ ><D.?_>HKX^7FVT^+;38_MR*#'&<
M_A3""#@U<9,\C\L5$5&>0,_05]%!:75KWZW_ $:/AW'>R7SO>_EJDBL1D8J-
ME &1GK_C5LJ",8 ]\5$RXZC(SQT_E5VUN[:+HG>_^1DUT:/\Z7_@O5^WM^V7
M\$/^"C?Q-\ ?";]H_P"*/@+P7I^@Z'<6'AOP[K[6.E6<L^H:]'*T%NL+!2Z0
M1*QR21&N3Q7Q?\-?B+_P7R^,O@S2?B'\+/$?[9OCWP1KT9FT?Q/X974=4TC4
M(PJMOMKJW@9&&V12.APP.,$9V/\ @X__ .4IGQ:_[%SP_P#^G3Q)7]NW_! >
M223_ ()5_LOF1W<1^&9HD+LS;(U>,K&NXG:BY.U1A1S@=:^2HT9XS'XJE+$5
MJ<8SJR3A)NUJK5K.226OZ'Z3B\92RK)<NQ,,#A<1.I3P].2J4XQWPZFY<T:<
MI.5UUWNVW<_BJ-K_ ,'&0!)L?VZP "2?[-UC@ 9)_P"/;L*QG_;P_P""^7[+
M<D>I^,/%7[5'A[2--D<73_$#X3P:[H)\MBTD5[K&N>!M2AC&5;).HQ.55]K[
M5;'^G[Y?O^G_ ->N6\4>"_"'C?3+C1?&7A;P[XLTBZ5DN-,\2:+INMV$RLC(
M?,M-2MKF!CL=E!,9(#$ \FO1>332O3Q^(4NC=[7_ .W:E_N/!_UKI2?+6R3
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M@?YYJ5DZD?EBHR,<&M$]N^YG*/6*VW6OWZ_H?4?[(''Q+US_ +$;4_\ T_\
MAFBI?V0P/^%E:YP/^1'U+_T_>&J*_+>+7?.:G_8+A/\ TW5/Z+\,=.%*-_\
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MP1XA@\+_  B_9DTP_"W0IH[*Q,_CA/#M]J%C%<OY]Q::7I_@>\L=%,]OM\J
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M^J?1I,_K2DZE&K3K4Y\M2G*,X25]'%W7JGLULTVGN?Y!7[&W[0_Q=_X)/_\
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M)P<#T_\ KU'@>@_(5JO2WE_PQ$Z;_'?_ (!0II4'Z^M6W W'@=NP]!4;*,'
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MI:?I>LZ5:0ZK+9-'+>Z?'#K=U,;"9VMGNXK2Y>-IK6%T^:_V)?\ @C3^P_\
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MW!B2.,RR;=TA2-%+$X4#BK5S;6]Y;SVEW!#=6MS%)!<6UQ&DT$\$JE)89HI
MR21R(Q5T=2K*2""#4^#Z'\C7C>@_';X>>)OC)XR^!.BZE/>>/O 'A[3_ !'X
MKM%MBEGI5MJ;:>;.TDN)'5I;V6WU73[S9##) MO<INN!,KPJ<R@X^]RMR2AJ
MT^9:I1::?,N6ZLTURW35KK%1G/GE&,I<D7.;2TC&Z3DWLES2BK]VD>!Q?\$V
M/V$8/'!^)$/[+_PM3QJ=4DUG^VQI-UN&IR2M.]TMB;TZ8K&5BXC6R$*D_+&
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M=_P47\%>#? 7[2&G>*M0\/\ @/Q0_B_0(_"FNPZ#<IK+Z3J.C,]S/-INI">
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M'X]GK:SG,K/_ )BI?^FZ!94X(/7_ #BI5D&X9&/Q]OI557 &"#Q2[QZ']/\
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M4\FL7UM>6NG2:9-I[7+Z%I[8,96W02M&F?\ M(?LS>/?A9^QW^PY\&M%\/\
MB/QIK7@#]H'2-;\2CP[H>H:W+I<6O:IXV\5:E<7R:3;WGV73M,NO$/V![^?R
M[?\ =QF1T:0*/K__ (*L>%/%'C']EV'2/"/AO7_%.JCXD>'+HZ7X<T?4=<U
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M +N,84)5(PS/V$9N'+.M3Q-J$:G-)*5J:E[.-22C)I)76_KOA'PK^V_^S_\
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MJ2M=Z)?Z;I?B"46TRSZAJLAN5?2;6XDL4U.-(H[B.42N9V5?,/@)\)OBI/\
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M_K[S+P?0_D:2K13 .2.G3/)J%D[@<>G)-*[ZKYK;Y_U\S%KHT0,HP3CG\?\
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M:=;>SH7+0<$XY_S^-.J $@Y%2*V< YS^%=G(M%L^M^JZM?H>6FGJO^&+"L,
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ML)!B5HT(B(((,8*X0@@$%<$$ CI2S6L5Q$\%Q%#/#( 'AFC66)P"& >-U9&
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M_A45.+;WMY6,I0VMLK[O\B%P >/3_&F,,@C_ #UJS43]1]/ZFG;7?1[IZ_\
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M=[*VUOQO^A?5NX[>M2*Y) X_R/K50'!R.U3*<@'_ #UH-"S3@V, ]!GZ]_\
M&JZ?>'X_R-2Y&0._?\B?\*4OA?H5#XX_XD61R ?6GA\<'H!VZ_SJJ"0<BI0P
M/UQSUK [BU3@Q7.,<^M5PQ7.,<^M!8MC..* +0?)P>^,8_KS4E5%?/7 Z8ZU
M,K$8'')H G5B..V>?6D8Y)/^>E)107#=^GZH4'!S4BMG@]?T_P XJ*B@U+%%
M1!R!CCBGA@?KCGK0 ZG!BN<8Y]:;10!+O'H?T_QI]5ZL5G4Z?/\ 0 HHHK,
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MJ$@@X-664C/IZ\?YZTP@$8-:IIZHR:MYK]?/S[K<^@_V9?\ D?-7_P"Q1O\
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M2W'ISSW[^_K[5*IP1DG'X_RJ!6Q@'IZU*"#R*R-RQUHJ$,1[CTS4F]?7^?\
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MGTS4)ZG'3)Q5AEQU&1GCI_*HBAZCUZ=,?K0!793QC)Z\9&!]*CJQTJ/R_?\
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M?_K531QD'C/IG_/:K .0#ZUW\K2NU:_G?7[W_D>*FKZ._7^OZN3;QCISZ?\
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MY/JM=>Q9IRG:<XSQBH?,]OU_^M1YGM^O_P!:L>5JVF^VQ:DGL_S+'F>WZ_\
MUJ>KDYQD=._UJ"G*VW/&<TDFW:VII&26^GWO\V_P+8<'KQZ=\_I4RMM&,9YS
MU_\ K54!&<@@XJ8,#['TS3Y)=OQ1HFGM_7WEE3N&<8YQ3@V#QV/(_#_"H V
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M.:/?\&2!CD<D_B:E# X]3V_^O4-*#@@^E!1/14?F>WZ__6I0^2!CK[__ %J
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M:]%T?8PE!WTUW^14P/0?D*A((ZU:*$8QD_A4> 3D@'\/K1SQ[_@R7"5OAO\
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M.S3[$;+U/Z8_"HZL4F!Z#\A5J6EFK]N_]?B4[/6_*^N[^:L045(X  P .?\
M&HZEVOHK>3$]][^84444A#'!., GK_2HL$=1BK%(0#_CZ5M#X5\_S @HIS#:
M<9SQFFU0"8'H/RIC)U(_+'\JDHH KT5,5!]!SG.*B(P2/0XH 3!]*" >H!^M
M3@ @9 / Z_2HRA&,9/X4'.]WZO\ -E<H1C&3^%1% 2#P,=L=:M4A48/ 'X"@
M"N5&#P!^ J)E(]QZXJP5(]3QG.*;0!6*@YZ9/?'-1%2">N!WQ5IEZG],?A41
MZ'C/MZTUNO5?F3/X9?X7^1!@'J,U$R8Y'.3T Z5,>IXQ[>E)6YQ--;E5P<=#
MU_QJ!D)QG(Z]1]*OE0?0<YSBHBIS]W./:@FSUU_!:%+R_?\ 3_Z]1U=* ]./
MPJ @8/ Z'L*"91TU=_DE:[MTT?G?Y$-1/U'T_J:EI" ?\?2G%V?;[NOJ92CN
MGK]Y7(!'OZXJ,I@$YZ>W_P!>K/E^_P"G_P!>F,,$CK_G-:WMO:W?S]%^FAFX
MZ:7:OMIIZ-_\,5J, ]1FI\#T'Y"FN..!W[#Z^E/I??\ 7[S-Z,ILI)/RY&3C
MCBH60CIZ],<BKV".H(_"HRF23GJ<]/\ Z]3;K'YQ>WGOY_(EJ^]V^^B:_P ^
MQ2JGY?O^G_UZT\#T'Y"JGE^_Z?\ UZTI:\UKQM;S[]]B'&3MJGZ67_#E/!'4
M8I, ]0#^%6G0#C@Y'7'3K4##:<9SQFMKZV>_Y_UYD-;ID10$\<?A32F!G.?;
M'_UZEHID.+M9._JE^>_XE9ESD8P?7'-1%2">N!WQ5TJ#GID]\<U"PP2.O^<T
M6N9VW5GHM;_C\CW#]G5<>-]5.>OA:^_75]#-%3?L\@#QIJF !_Q2][V_ZBVB
M45\1GVF82UO^YH?^DS/V+@G_ )$-/_L,QO\ Z<HGV37\_P#7] %?S_UXQ]:>
MP?#YB-&N0#_S$YO3_GULJ[K>WK^@_P *X+P"P71[D'/_ "$YO_26RKN@P/\
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M$< U6Z5.I) )_P \UG/OKYIWW_+[F:*3?VK]=R56)(!/Z#TJ=6.0,\<^GO\
MUJJ"0<BI588&2,_4>M0:*;TO;=+K?UV+BL&X)! &1R/_ -?>I"P &,'MC/\
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M_P"%1?"KX@?$W_A&?[4_L3_A(?\ A!?"FJ^)_P"Q/[9_L[5_[)_M3^S/L/\
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M?#5'2G.OCZDZ,*/+/VWU;YC\'_'?_@Z!^,G[/UO_ ,%)O!'Q _9!\-? Z_\
M >I_&'PS^Q[)X/T*YU_Q;\-K+2K[5K&^L&G^'>O^+';6M$":[I5A>?M+>'/$
M%XL%HDNGZ=+=-I%S^H?P7_X*.>&?^"GW_!%C]JO]H;3O#UKX)\;Z9^SI^TI\
M/OBYX#L[Z34;'PM\0=!^$.MWMVNCW=P%O)_#^NZ/JND>(-$:]4W=O::D=-NI
MKJZT^>ZF_EJ_8Z_X)R_\&[OQC_8P\ ?M"?M#?\%&?BW\%_BO;>"4NOC=\);O
MX]_L]^'_ !?H'CK18?)\4VO@/X1:K\ /$/Q6\5Z#?W<;7_A"#PU9^-=0U+3+
MNVLX;W4]4M[Q$_I!_9=_9&_8._92_P""1W_!0B/_ ()\_M$^*_VD_@]\3O@Y
M^T)XFUGQEXG\?_#_ ,?G3/%^C_ [6M O-$L[KX?^ OA_:Z0\-A;6,][IFL:5
M-JHDEAG:9;66WC%\145A^'^/\).,98+#\-8Z66*EBXYQ6PF+5&O>I6SB$:4\
M5@<TRZO*2GB*,*<,73HSPT<*ZKP%.,H=*MQ%P-BJ494\9/C?):.(E_9TLFPN
M(P2SK+5/#1P%2<X+%Y;B*.'J4IT9>VJX:I4]L\12?MX_SE_\$&_^"[7[(W_!
M+O\ 9:^)WP1^/_PZ_:.\7^*_&GQTUCXG:7J'P>\(_#+Q!X>M]!U#P+X$\,0V
MFH7?C3XO?#[4HM76_P##%_-+;V^DW5DMG-9R)J#S236]ORW_  5/_;3\+?\
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ME[O_ ,%K/^"DG_!3#_@EQX>_X)<Z'#\>M \5?$WQ;X4\5WG[7 \'_#CX4_\
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M'X"_\$__ /@I9_P7_P#^"D7BW]H[]FG]F[X[_!VU\<>!O$T'C"Y_:/\ C/\
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MK%(W0_0_RK=2LDDOQVU.5*[WZ-_<B"BB@@'@U4I.-M-.K!)/=V?3L%! /!H
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M<V/D_P#IS0_])F?KG!J:R.FG_P!!>-_].4CZYK^?^OZ *_G_ *\@^J/3_!3
M:7..<G4)?UM[05V08CH?Y5Q/@S_D&3_]?\O_ *3VM=B'XYSGVQ7ZAD\7_96
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M#_ZU6HW;GGT[#W]JHT]6"YSGG']:#12M>]W>VM[/3S-0,&SC/'K2]*I"=<C
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MJ4N&>(J]"KF$*53!8?$T<N53#8K$JM3J0CA\-6C3KUY\J<,-2Q+4HKFNL?\
MP1/_ .#D&14=?^"N! =0ZY_;V_;O! 9=PSCX4GG!YP3]:_;:T_9=_:8^%G_!
M'VY_9W_:^_X*5?\ #/7Q^TN[FE\9_M__ /"Z?'^O?\(A!J/QQ7Q1X;B_X6S\
M3_&'P)\:3?VKX:N=)^&NS5?%?AM(?[2_L6P.JV"6UG??B/$?^#R[RXS%_J]B
M[/\ E%=]S "_>^;ICKSZ\U^K'_!:-OBZ?^" /Q#'[0!_XOM_PJC]E[_A<O\
MR+/_ "5#_A8WPE_X3O\ Y$K_ (H[_D9_[2_Y%7_BGO\ H#?\2_[/4XJK3P?#
M6?XBG1J>RE6RBA6PF85\12QM51QU/$4:V#K4ZBQ-"A2G4=/&U,/5INK-X7"5
ME.A4G%^MEZQF/XDX4P%;'91.>(QU2I3QF28/+\12PU58#$4I2Q5&MAY87$0J
MQJS>%P^+HUJ$Y*59157#TI1_1C]CGQ/\,OV7?V#_ (9ZU\8/^"@_@/\ :?\
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M];FTTD7=Q U_9B6-3=0!XO#W[2?[.OB[XHZ]\#O"GQ\^"OB?XU>%H)KKQ/\
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MO^#>/_@IS^UG^T=X]_:?_8:_;CU(^,_CC^RY-J%[!\2+N/1H_$%S9:#XQN/
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M(MX8\#^$=.^.GQ?^*'A#P)X<^*6O_P#")Q3VNNV7BOQIXL;3-7UCQK9:7?\
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MXKV%-36*I5*$'B%5PV(IU5_<?\8_VG_V:?V=DTR3]H']HCX%_ M-;D,6C/\
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M/[$AG='#TN>KR5,)GF'PV'K8>I-S]NJM"-&K56.]M/%8BOB9RKQC1IT\+/\
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MIOXB?\$\_P!FV?\ :H_9L_:?\0/J.@VND_"KQU\<+/1K6YU?Q%XF\/Z1XF\
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M4_[/P^4S]I@I2A0KTZ.'A4Q7L(U(RQ,U/"2E&E7<E_%Q_P $Z?B3_P %J_\
M@CSI?C#_ ()Y?\.LOB!^V)X>N_'?B3Q-\$_BQX,\4:SX5^$FA2>(?M"7U]JO
MQ:M_ WC'X=+X1UJ]TB/Q);>&O&GB'X7>+-&NM1O;75)X9=:TR"U\5_X(M^&/
MVB=*_P"#D']JF']I_4/"-_\ M"0_#KXY^*/BW+X,O]0U7P=IWB3Q;<?#O6!H
M?AFYU*.UOKG1?#4?B/3/#UE;L\D=O::9]FM-0O[6"#4+G]%M(_X)._\ !P=^
MRCJGB7P=^PU_P5U\"^*_@QK^I7.K6<?[6-MJ_BGQMH)%U>Q:?I>G0^.?@?\
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M3K0IUJ52$HU*=2+:;C4J1E_ =\8OVM_^#G[_ (*$> O%?[$FH?L'ZK\$=/\
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M4(4Z.&R7&+,,ORZ'M'A8XYN*>+Q#<XU\37]E%T*=6=6$Z%.<YT9PQ"H5L-_
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M&ZXP1C_B8Z7ZT5\IG&N-E;_GU1_])F?IG"R:RB"::_VG%;Z?;IGTS7\_]?T
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MI%WZ-KO=?EN6E;&>,YQWJ4$'H<U35B,X!([#)X_G_D5*#Z'\C_A4&BMZ>?\
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M>>/QH%=7M^C_ #V_$?3E;;GC.:;10#5_)K9CF;=CC&*;110/\0HHHH ****
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M[_X4IXKAUC3OV@[36[>RO?BO_P )2_A=/ O]I2>)X[GQA]JMO%,OCNXNKO\
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M2<Y/I_6GT%)W5R<$$9%+4 8CH?Y4N]O7]!_A0,FHI%)(!/\ GFEH ***D 3
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M?J?\:B/!/U-'.NS_  _S$XN.]B-DSTZYYZU$>"1Z58INU3V_4_XT<Z[/\/\
M,DAI^P^H_7_"G[%]/U/^-.JE)2O:^A$HN5K6TN5Z*,$=1BBF3R/NOQ_R"FLH
M.?7UY_STI3T..N#BH]S^_P"7_P!:@.1]U^/^0TJ1V_'M2$ \&G%B>"?T%-H#
MD?=?C_D>H?"10/$E[@?\P2Y]?^?_ $VBE^$G_(QWO_8$N?\ TOTVBOF<U_WR
M7_7JE_Z3(_0.'%;*X)_]!&)_]+IGT/7\_P#7] %?S_UYI[ILZ=_J'_ZZM_Z
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MQ R[*HZD@5\!?\%T/&?Q._88_P""CW_!0'P5\/5@M_!G_!1;X ?#J3Q#$^Z
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MT_G3BP! YYK)Q:TM_7<:;6WS1.'!..>?7'^-.JO3U;'!Z?K_ )S4M?-VMO\
MU]YI&2>W1;6_6^OH3 X.:G1NC'WZ?B*K Y&:>IP<UFX-:]-_3R\_4T3U3V^6
MWR+@8$X&:=4"MCD=QWJ16).#CI_A4^FGS-[[/?;\BPK$YSVQ_6IX^_X?UJG4
MD??\/ZUG*-[M;^IM&5_7KIH6PP;IVI1P0?2J_2I0^>#U)[=/YUFTUHS6,K?-
MK1+Y?TNI94DC)]?\*E#X7'?].OUJI4R?='X_S-2DE>W7IT-%+WM[6Z-:^N_X
M%E3D _YZTM0 X.:D5L\'K^G^<46MMU=WK_7W&ZE\UW2M;R:+.0%!]@./I_\
M6J=&!  ST']*I5.O0?0?RK.5ELTW=W+3\DU_74LU(']?T_KS5</@8/;&,?UY
MJ2LVD]S2+TTU\DMO77[O0L58JBI(./4BK.\]P/\ /XTRXM[IK7:Z^7XO8F7J
M/J/YU/58$$9%.'!!]"*F4;ZWV1LI7:3WL[JW7UN6 <'([5,IR ?\]:JA\MCM
M^O3ZU(#@YK)IK?32_P#7F47XB% )]#_.KBN,#@]!Z>GUK*1^??'/I_//I4ZR
M@<XYQSQQ_.H<4]=WZV+4K+M_6_G?MIZE_>/0_I_C3^M5$?=^61_G-2!BO3O6
M4M'9::*U]?-V[_@:)WZW?I;TTU+P8-G&>/6EJL&#9QGCUJ4/Z_I_7FD5%M;=
M;$E*."#Z$4T,"">>* 01D4&R=]NCZ_>6489!YP,_7I4N\>A_3_&J8.#D=JD#
MCN#GV_\ UTM5YKRW]+?K^!?.U?;5WV-",Y0$>_\ ,U95@<#G@5G(<J"/?^9J
M97QP>@';K7,[J4G%W]YMQV>_YEJ6S:M=;]^OR[EX$@Y%2!L],9[YZ?ACWJJK
M\#(XP,>OX\U*.0#ZTT[[/;=6_KJ63E@N,YYI:KTX,5SC'/K0U=692?;1KOL_
M\OQ+>\>A_3_&G @C(JN&#=.U.7J/J/YU+3:U6JZK7]5;\33F6VS[/0GKQOXP
M?LV_LZ_M$6^@6W[0'P#^"OQTM_"LU_<>%X/C%\+/ WQ-A\-W&J+:IJ<^@Q>-
M="UM-'FU&.QLDOY=/6V>\2SM5N&D6WA">R4JG!!_STK"4(3Y>>$)\DX5(<\(
MSY*E-\U.I#GC+EJ4Y>]"I'EG"7O0G!ZF]*O5HMRI5:E*7+.'-2G4IR<)QY9P
M<J=2E+DJ1]V<7)QG'W9QG'W2MH>C:)X9TFPT'P[H^F:!HFEVZVNF:-HFGVFE
M:5IUJA)2VL=.L8K>TM+=,G;#;PQQJ2<*,FMM'&T<'OZ>I]ZH[QZ']/\ &G*X
MR,=??_ZQJVW)N4FY2DVW*3<I-O5MRDVVV]6VVV]6V]1QT222C%12245&*MLH
MI6226B2BDELEL7E8DD=NWKUI]558'COCGTJ12 <GT_PI%$U3C=WQ^']?_K57
M#!LXSQZT\,5SC'/K4S^%_+\S6G)N<4[:7Z>3+*L!G/?']:EJL&#=.U/5B/IG
MG_ZU8G66%8CZ9Y_^M4H((R*K@@C(HR,@=S_]?_"@"S3U?&!V_7^=5U;'!Z?K
M_G-2 Y&: + .1D=ZA;J?J?YT D'(I#R2?6@NGN_3]296!P.>!3JKU('P,'MC
M&/Z\T&I)1110 HX(/H14P((R*@H'!!]* +%%1JY) X_R/K4E93W7I^K ****
M@!RD Y/I_A4@8'IG\:AHK2,4XWZZ_P!6*4FM.G]=2Q148?U_3^O-24E>#U6_
MX^C#EOK'7RZH****EN[;):MN%%%%("9/NC\?YFG4U/NC\?YFG4&ZV7HOR"BB
MB@9.O0?0?RI:B#D #CCZ_P"-2!@V<9X]: %I0Q ([&DHH **** "BBB@ HHH
MH$FGMJ0LI!)[$FFU8J.3M^/]* 2ML]-[6[^9'1110,*@E4,P)ST_J:GJ)^H^
MG]3513;T=M]29[?-;D8  P*6BBFX/??\R%-K>UO+2P4445+36ZL:)I[,****
M0PJO5BJ]:4^OR_4SJ=/G^@4445H9A2,,@C_/6EHH @(P<4E3D9&*C9<9(Z?K
M_G- 'I?PH_Y&*]_[ MS_ .EVG44?"C_D8KW_ + MS_Z7:=17S.:_[Y+_ *]4
MO_29'WG#W_(MA_U_Q'_I<#Z"K^?^OZ *_G_KS3W"S P ]]W'7T&*N!QCG@_0
M_P#UZJ0?</\ O'^0J:OV?((IY)EE_P#H$CK_ -Q*Y_(O',VN,.(DDO\ D9U%
M_P"4,"6 0>13T!R#VY_PJL'(&./\_C4BR 8)QGZ&O8MI;I:Q\PKZW[Z>A9YR
M>..Q_+W^O:G D'(J)9,\G&/H:DZTN2/F7'=7V>C[,G'(!]0*F#* .>P['_"J
MBD \^G^%2@@]#1RJUM=&W]YKIUZ;/9:Z;W[$H?U'Y?\ US3U8$YYX(J"G*VW
M\<9_^M1[_9>G<IR;WUMUZES<I[_H?\*<."#Z55WKZ_H?\*>D@R%!')'8]\"D
MVVMFNZL_S[?+[BU-MZV7R;_4N*S'L,=S_DT^H <'-2JP./7TY_STK(T3U7=:
MWMH]?7<D4@$$_P">*E# ]*@I02#D4VHM/>]MKZ/;RW-%)M]+M66GGZ^I:#XX
M/0#MU_G3MX]#^G^-5@_/. /Q_P#KU)UK-PCOM^1MSRV[)=-"TCKSU/3M]?7%
M3"0+G!'/J#5$,5SC'/K4BL6SG'&/ZUF[MZZ,TA-^E]K=;%\/US@>G!_^O3@0
M>E55?/7 Z8ZU*K8XXQGFLW%.[6K\V:\[L]K]--+=2TK  Y]>GY?A4RN<# &/
M?KU^M5 0>E/#D#''^?QK/:^GR=S2G-W>WW=/O+8<8Y//T-.# G /Z&JRL#CU
M].?\]*>#@YI&RDV]=MD[/?IU+:OV/0"I.M4P_/. /Q_^O4R$ YSP1_A42;3;
MLE?1:WV-(RDE9VW9;#* .>P['_"IE8+G.><?UJIUIZ$#.3Z?UK(M5&K-6OK>
MZT_,M;Q[_P"?QJSO7U_0_P"%4 0>AJ97SUX.>*#:$[KHGVMZZ;_=ZEI77(Y[
MCL?7Z5/O7U_0_P"%4:<&(&!B@U3OOH^VWW%Y77<.?T/I4X8$X!_0U1C.2I/O
M_6K .#FL9.[?E=?B:*;6_1::=>A/3PS=  <#_/>HE;/U[BG5)2E?1Z/TT\O4
MN1/LR3U('N/?I4@E SR.>N0:SZF4@@<Y( S4."EOK?ML:J36UEMTW_'YFB"#
MTJP&#9QGCUK/!!Z&K2..<<],\'].E)P26C?S:_R1:D]+V]5K?T[VZD]*.HQU
MR,4S>OK^A_PIP(ZCG!K,U4VDEH3C..<9]J6F*V>#U_&GT%J6MFO1K9_UW+$<
MBJ@!SD9[>I)J02H3@9_*J=*"0<BLY4TWS:\VZU_K0T3:371FB)D  R> .U2K
M(HY!ZCN#6<&!^N.>M2IU/T_J*7LHO7WD_6VWR*@VK*VC>GJ:>]?7]#1O7U_0
M_P"%0T57(N[_  _R-E:^NWD61P0?0BIE=<CGN.Q]?I5<$'H:4<$'TH<%9ZO9
M]NS\AIJRO>ZVM]^OS_ O;U]?T/\ A1O7U_0_X54#G(SC'?K_ (U*"#R*YG!=
M+[Z^GEYEJ3OK:W=:Z^98!!Y%*IP0?\]*A5L8!QC\<U*"#R*%"[WT_'T]?ZL:
M)M:HL Y&?6IE(( [@?RXJHG4_3^HJ6GR+S_KY&L6VVGV3VMO\RVA SGO3E8G
M/'Y?_7-5PR@#GL.Q_P *?4S@N5ZOIV[^A<9.+36Z[_<3Y/H?T_QJ4/ZC\O\
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M?^O//<)XF*J0,=3U^@J97SUZYXZU60<9R>O3/';K4E?M'#__ "),L_[!(_\
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MOQ^?/Z4^LWO:2MV:_K7H;%Q6 ')YS[GTJ12"0>V>:I!R.O/X_P#ZZD5^,\@
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M_P"'_$MJPP,GG\?6G@@\BJX(/(IX?  QT]__ *U3OZW^7W>IN6 ^ !CI[_\
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M_8'N/_2W3Z*^>S+_ 'I_]>Z?_I,C[?(?^1='_K_7_P#2H'O%?S_U_0!7\_\
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MKJ7L@]"#1]*A5P,]^G0].M3 ^A_*L4T_\GN4F]]/D]"9<XYSU[_AZU,A ')
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M YR<<^M5PP..F3VSS3@2.14&I/1DCH<4Q7SP>..N>M.R#T(/XT 6 0>AS2U
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M?\AZ[_[!%Q_Z6V%%?/9E_O3_ .O=/_TF1]OD/_(NC_U_K_\ I4#W.OY_Z_H
MK^?^N ]D:S;3C&>,]?\ ZU 8'V/IFF/U'T_J::."#Z'-?MO#MUD>5M:_[)#3
M3_GYB.N^A_'G'G_)9<2?]C2I_P"F,"3T4S>/0_I_C2AP3W'UQ_C7MGR1.I&T
M<COW]S3ZKU('  '/ 'I_C25[NZTZ,"2BF;QZ']/\:-X]#^G^--I/=7 ?1116
M/++LP"E'4?4?SI0I(R,4%& /(Z'U_P *7*[7L[%1=GJ]+/T)<CU'YBC(]1^=
M5@&[G\,#^=/4X(/^>E(U4TMI6^\GIZ$ G)QQ_45$)%SR#C\/\:=O1N%!!Z\^
MGYFAZJVQ49QNKR>^VZ+%/#D>XQC'3^E5EDYP0< <<#'&.]2!@3@9J$I7LUS+
MOV^>YM==_,M^8?[P_2IEDZ]%Z=2.>OJ*H@9[@?4XJ8YXP<>M)P>EM?N7_#C+
M&1ZC\Q2U7Z5*K9')&<^WM2M/N]^^IK&3>[]?7I:RV]23!/0$_A4\;%5 [<Y'
M3^E1*P P<]?\*-YSD=/3\/QJEH];V75MZ_+8TB[/7;I:_P");# C.0/;-2*Y
M&.X_#^?UJD'R0,=??_ZU3JX  Y_R?K3T>C=[Z_\ #;??N:*:OTMWU_R+1<
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MR*Q::[^K77[V:QE9>3>FNJ7W;?U8OJW<<9_S_2IE8' [X_.L]'/XXYX'K_\
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M.2IZ<G'Z"G*Q'';//K63BU?MW-5+JF]6G>_YEE78$'/Z#TJ4,3\W?\/I]*K
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M-M_[NGXP X.1VJ93D _YZU^S-%1_K?\ ]2__ ,NO_N _^(6]/[<TO>W]G?\
MWZ?C6K@ #G_)^M2#D ^M?LA11_K?_P!2_P#\NO\ [W-%X86M;.]MO^$__P"_
M#\< 2#D5*K _7'/_ -:OV*HI/BZZM_9_I_M6W_E I>&+3O\ VW?O_P )^_\
MY>'X];S[?Y_&I:_8"BI?%B>V7V_[F?\ [@5_Q#/_ *G7_F/_ /OP_(56+9SC
MC']:>O4?4?SK]=Z*7^M?_4!_Y<__ ' K_B&NU\Y;:Z_4+?\ NV?D?3T8Y [<
M_P"-?K;11_K9_P!0'_ES_P#<"O\ B&_3^V?_ "P_^^S\EZ<GWA^/\C7ZS44/
MBNZ:^H;_ /43_P#<"EX<M?\ ,YNNWU#_ .^S\GZ4$@Y%?J_16?\ K1_U!?\
MEQ_]Q*_XAU_U-_\ RQ_^^S\I-X[@_P"?QJW$_7/MT_'KS7ZH44GQ/=-?4O\
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MMLSM_P!RG_WP?GTG4_3^HJ8$@Y%??]%']N_]0O\ Y6_^Y%+@Q]<RO_W*6_\
M=@^!ZDC[_A_6OO2BC^W?^H7_ ,K?_<A_ZF?]3'_RT_\ O@^#@P;.,\>M/5B.
M.V>?6ONZBH>=7;?U;?\ Z??_ ',VCPERQ4?K][=?JWF_^GY\+ @C(IX8@8XK
M[FHI?VS_ -0W_E7_ .YE?ZJ?]1__ );?_=SX9W'.[C/Z=,4]6SP>OZ?YQ7W'
M11_;/_4-_P"5?_N8?ZJ?]1__ );?_=SXC1B>/0?X5)7VQ11_;/\ U#?^5?\
M[F'^JG_4?_Y;?_=SXGHK[8HH_MG_ *AO_*O_ -S-/]5_^H[_ ,M__NQ\3T_>
M>X'^?QK[5HH_MG_J&_\ *O\ ]S#_ %7_ .HW_P M_P#[L?%P((R*6OM"BC^V
M?^H;_P J_P#W,/\ 5?\ ZC?_ "W_ /NQ\7TY/O#\?Y&OLZBAYS=-?5]_^GO_
M -S#_5?_ *C?_+?_ .['QO17V116?]K?]./_ "K_ /:!_JO_ -1O_EO_ /=C
MXWHK[(HH_M:VU#_RK_\ :!_JO_U&_P#EO_\ =CXWHZ5]D45:SG2SP]_^XO\
M]S#_ %7_ .H[_P M_P#[L?'JDD9/K_A3J^P**EYMK_N]O+VO_P!H4^&;JWUW
MY_5__NQ\?T5]@44O[6_Z<?\ E7_[0G_5?_J-_P#+?_[L?']3KT'T'\J^N:*/
M[6_Z<?\ E7_[0J/#/+?_ &V]_P#J'_\ NQ\CT5]<44?VM_TX_P#*O_VA7^K?
M_49_Y;__ '8^1Z*^N**/[6_Z<?\ E7_[0/\ 5O\ ZC/_ "W_ /NQ\DJQ! [$
MBIJ^L**/[6_Z<?\ E7_[0/\ 5O\ ZC/_ "W_ /NQ\GT5]844?VM_TX_\J_\
MV@?ZM_\ 49_Y;_\ W8^3Z*^L**/[6_Z<?^5?_M _U;_ZC/\ RW_^['B/PU_Y
M#MW_ -@F?_TLL**]NHKS\37^L575Y>2\8QY;\WPIJ][+>_8]O 83ZCAUA_:>
4UM.I/GY>3XW%VY>:6UM[ZWV1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>eximg_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 eximg_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M_P!!;1__  6'_P"+H/Q/^( _YBVB_P#@M/\ \75'Q3\0-'\(>-_#'AZ^%_\
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M?S%-/AME_A_2J^KX7^1$_6\P_P"?LOO-@_M5>.L?\?&E?^ 7_P!E33^U9XZ
M_P"/C2?_  #_ /LJQO\ A&\=OTIC>'.?NT?5\+_(B?KF8?\ /V7WFY_PU=XZ
M_P">VE_^ 7_V5-/[6'CD?\MM+_\  +_[*L-O#A_N_I33X;/]W]*/J^%_D1/U
MS,?^?TOO-[_AK#QS_P ]]*_\ O\ [*E_X:P\<?\ /?2O_ /_ .RKGF\-D#I^
ME1MX=X^[^E5]6PO\B#Z[F/\ S]E]YTA_:S\=#_EXTO\ \ __ +*D_P"&L_'
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M3>,/"WA#Q[XWM+&.1/#D5],\:R22R9A-ZD0**)%)C-Q$S=A7C7[8'CKXF?\
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M5X;L]8\2_#F]?4?#6I---!<:1.X =D:)UW*P5<H^Y"54E20".+\._P#!.O\
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M/Q^^-5C\1/&OP?\ !_B;QI8)$HU.]BD_TSRHUCC-U KB"Z*HB*#<1R855'0
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M4WAD8Z4S_A&\'I7;G24/\/Z4UM'4G[OZ4_K#%]21P[^&?]FF-X8QV/Y5W/\
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M_GY^!\6?\+!TW_H(VW_?P?XTX?$/30?^0A;'_MH/\:^T?^&6_AQ_T)'AG_P
MC_PH_P"&6_AQ_P!"1X9_\%\?^%']N+^4%P?)?\O?P/B__A8VF_\ 00M_^_@I
MP^(^F_\ 00MO^_H_QK[._P"&7/AS_P!"1X9_\%\?^%'_  RW\./^A(\,_P#@
M!'_A2_MM?RC_ -3Y?\_?P/C'_A9&F_\ /_:_]_!_C3O^%EZ9_P _]M_W]'^-
M?9G_  RW\./^A(\,_P#@OC_PH_X9;^''_0D>&?\ P7Q_X4?VTOY1_P"I\_\
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MH_\ S^1_]]K_ /%5]:?\,M_#C_H2/#/_ ( 1_P"%'_#+?PX_Z$CPS_X+X_\
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M_P -<>$O^>M]_P!\P_\ QRE_X:X\(_\ /2^_[YA_^.5[Q_PRW\./^A'\,_\
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M ,*/KU'^1_>']DXO_GZO_ 4>&G]K[P6?XM0_[YA_^.T?\-?>"_[VH#_@,/\
M\=KW+_AEOX<?]"1X9_\ !?'_ (4G_#+?PX_Z$CPS_P""^/\ PI_7J/\ (_O#
M^R,7_P _5]QX;_PU[X,_OZE_WS#_ /':/^&O?!F?OZE_WS#_ /':]R_X9;^'
M'_0C^&?_  7Q_P"%'_#+?PX_Z$?PS_X+X_\ "E]=H_R/[P_LC%_\_5]QX8?V
MN_!?][4?^^8?_CM'_#7?@S^_J/\ WS#_ /':]S_X9;^''_0C^&?_  7Q_P"%
M'_#+?PX_Z$?PS_X+X_\ "CZ]1_D?WA_9.+_Y^K[CPP_M=>#3_P M-0_[YA_^
M.USOQ!^/7AWXD?V%8:;-<"X76+67$PC4,/,"X&UV.<D=J^E?^&6_AQ_T(_AG
M_P %\?\ A4MI^S-\/;"[AN(?!?AN*:!UEC=;",,C*<@@XZ@@&G]>I+:+OZ@\
<FQ,M)U%;3IV=SLF*[CQW]:*FQ17D<I]-S'__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
